we're here to support

The SmartMat+ is a remote temperature monitoring device used to detect signs of inflammation. It is a home-based device, roughly the size of a bathmat, that measures temperature at the bottom of a patient’s feet. By detecting subtle increases in temperature as an early sign of inflammation, the SmartMat+ can help identify areas at risk of developing a diabetic foot ulcer, often up to five (5) weeks before one appears as demonstrated in a Podimetrics sponsored randomized control trial. This early detection enables timely clinical intervention, helping to prevent ulcers, hospitalizations, and amputations.

The SmartMat+ is cellular enabled and does not require WIFI, a smart phone or an app. Patients simply step on the SmartMat+ daily for 20 seconds, then go about their day. The patient’s scan is sent securely to Podimetrics to analyze and monitor the scans for signs of inflammation (“hot spots”). If inflammation is detected between two consecutive scans, the Podimetrics care support team reaches out to the patient to initiate education and offloading protocols. In most cases, our virtual care support helps to reduce signs of inflammation, with no need to notify or alert the provider. In addition to inflammation monitoring, the Podimetrics care support team will reach out to re-engage patients and provide wellness check-ins. Patients can view their scans via the patient portal.

Provider participation is minimal. Providers are asked to:

• Verify the patient meets inclusion criteria for the program, and sign the prescription for the SmartMat+ 
• There is no dashboard to monitor, or any additional administrative work required by the provider while a patient is  actively monitored between regular office visits 
• Provide routine clinical care if a patient requires medical attention due to persistent signs of inflammation or subjective  patient findings that might require the patient to be seen in clinic

Podimetrics provides alerts to providers offices for any clinical notifications or escalations needing attention or action. Our goal is to minimize the burden on provider offices by handling most monitoring and patient engagement between  visits. Our team reviews all data and only reaches out when a clinical notification truly requires provider input. Thanks to  our virtual care support, roughly two-thirds of inflammation alerts are resolved without needing a clinic visit. On  average, patients are escalated to in-office evaluation 1-2 times per year. This approach not only reduces routine  workload and unnecessary visits but also ensures that patients are seen at the right time and in the right care setting,  helping prevent ER visits and hospitalizations. 

● Have a history of DFU, partial foot amputation or Charcot Foot in the last 24 months

● All Members covered by Aetna and deemed eligible by the Plan

● Once identified, Aetna supplies Podimetrics with a list of eligible members who qualify for the program. In this case Podimetrics will reach out to the provider office with a request to review any of their patients from the list. 

There is no cost to the patient or provider. Aetna is covering the program at 100%.

Proven Outcomes:

• Device Effectiveness: 97% of DFU detected approximately 5 weeks before wound opening¹
• Device/Program Adherence: 75%+ of members actively scanning each month after 12 full months²
• Amputation Reduction: 50-70% reduction of Amputations^2,3
• Hospitalization Reduction: 30-50% Reduction of all-causes inpatient stays^2,3
• ER Visits: 10% Reduction of all-cause ER visits³
• Skin Substitute Reduction: 60%+ Reduction of use of skin substitutes²

1. Frykberg, et al. Diabetes Care 2017
2. Internal Podimetrics Data on File /Client Studies and outcomes
3. Isaac, et al. BMJ Open Diab Res Care 2020